Disopyramide Phosphate Market by Brand (Norpace and Rythmodan), and Patient Type (Geriatric, Adolescents, Children, and Infants) - Global Opportunity and Forecast, 2017-2023

Get 20% Free Customization In This Report

Pharmaceuticals	LI_183811	Pages: NA	Mar 2019 \| 899 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Disopyramide phosphate is a class I anti-arrhythmic drug used to treat cardiac arrhythmias. It interferes with the depolarization of the cardiac membrane that results in depressant action on the heart rhythm. The drug is used to treat arrhythmias and prevent paroxysmal supraventricular tachycardia.

The factors that drive the disopyramide phosphate market include increase in the prevalence of arrhythmias and ventricular tachycardia among patients with heart problems, rise in R&D activities to develop advanced products, advanced healthcare set-up, and growth in geriatric population. However, side effects associated with drugs and stringent government regulations towards the approval of disopyramide phosphate drugs restrict the market growth. Increase in clinical trials and development of drugs with better efficacy and lesser side effects biologics are expected to provide a number of opportunities for pharmaceutical industries, thereby fueling the market growth in the near future.

The disopyramide phosphate market is segmented on the basis of brand, patient type, and region. Based on drug brand, it is divided into Norpace, Rythmodan, and others. According to patient type, it is segmented into geriatric, adolescents, children, and infants. Geographically, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Sanofi, Merck KGaA, Teva Pharmaceutical Industries Ltd., Santa Cruz Biotechnology, Inc., Mylan N.V., Interpharm Holdings Inc., Watson Laboratories, Inc., Sandoz AG, Pfizer Inc., and Aurolife Pharma LLC.

Key Benefits

The study provides an in-depth analysis of the disopyramide phosphate market with current trends and future estimations to elucidate imminent investment pockets.
The report provides information about the current and upcoming trends in the global disopyramide phosphate market from 2016 to 2023, which helps determine prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the global disopyramide phosphate market has been provided.
Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global disopyramide phosphate market.

Disopyramide Phosphate Market Key Segments:

By Brand

Norpace
Rythmodan
Others

By Patient Type

Geriatric
Adolescents
Children
Infants

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 DISOPYRAMIDE PHOSPHATE MARKET, BY DRUG BRAND

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. NORPACE

4.2.1. Growth factors and opportunities
4.2.2. Market size and forecast
4.2.3. Market size and forecast

4.3. RYTHMODAN

4.3.1. Growth factors and opportunities
4.3.2. Market size and forecast
4.3.3. Market size and forecast

4.4. OTHERS

4.4.1. Growth factors and opportunities
4.4.2. Market size and forecast
4.4.3. Market size and forecast

Chapter: 5 DISOPYRAMIDE PHOSPHATE MARKET, BY PATIENT TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. GERIATRIC

5.2.1. Market size and forecast

5.3. ADOLESCENTS

5.3.1. Market size and forecast

5.4. CHILDREN

5.4.1. Market size and forecast

5.5. INFANTS

5.5.1. Market size and forecast

Chapter: 6 DISOPYRAMIDE PHOSPHATE MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Disopyramide Phosphate Market by Drug Brand
6.2.5. North America Disopyramide Phosphate Market by Patient Type

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Disopyramide Phosphate Market by Drug Brand
6.3.5. Europe Disopyramide Phosphate Market by Patient Type

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Disopyramide Phosphate Market by Drug Brand
6.4.5. Asia-Pacific Disopyramide Phosphate Market by Patient Type

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast

6.5.4. LAMEA Disopyramide Phosphate Market by Drug Brand
6.5.5. LAMEA Disopyramide Phosphate Market by Patient Type

Chapter: 7 COMPANY PROFILES

7.1. SANOFI

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. MERCK KGAA

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. TEVA PHARMACEUTICAL INDUSTRIES LTD.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. SANTA CRUZ BIOTECHNOLOGY, INC.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. MYLAN N.V.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. INTERPHARM HOLDINGS INC.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. WATSON LABORATORIES, INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. SANDOZ AG

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. PFIZER INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. AUROLIFE PHARMA LLC

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Disopyramide Phosphate Market by Brand (Norpace and Rythmodan), and Patient Type (Geriatric, Adolescents, Children, and Infants) - Global Opportunity and Forecast, 2017-2023

Disopyramide Phosphate Market Key Segments:

By Brand

By Patient Type

By Region

PURCHASE OPTIONS

Reach out to us

Request TOC/Sample

Request Customization

Request TOC/Sample

Purchase Full Report of
Disopyramide Phosphate Market- Global Opportunity and Forecast, 2017-2023

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

About

Contact Us

Find Help

Get notification about our new releases

Our Products & Services

CONNECT WITH US

Press Media

We Accept

Disopyramide Phosphate Market by Brand (Norpace and Rythmodan), and Patient Type (Geriatric, Adolescents, Children, and Infants) - Global Opportunity and Forecast, 2017-2023

Disopyramide Phosphate Market Key Segments:

By Brand

By Patient Type

By Region

PURCHASE OPTIONS

Reach out to us

Request TOC/Sample

Request Customization

Request TOC/Sample

Purchase Full Report of Disopyramide Phosphate Market- Global Opportunity and Forecast, 2017-2023

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

Purchase Full Report of
Disopyramide Phosphate Market- Global Opportunity and Forecast, 2017-2023